Caricamento...
Bevacizumab in Glaucoma: Where do We Stand?
The use of antivascular endothelial growth factors such as bevacizumab and ranibizumab has brought about a revolution in management protocols of various ophthalmic disorders. A lot has been written about these agents, still lacunae exist in our understanding due to paucity of randomized control tria...
Salvato in:
| Pubblicato in: | J Curr Glaucoma Pract |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Jaypee Brothers Medical Publishers
2012
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5161771/ https://ncbi.nlm.nih.gov/pubmed/28028350 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5005/jp-journals-10008-1110 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|